Kidney cancer statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Cases

New cases of kidney cancer, 2015-2017, UK.

Deaths

Deaths from kidney cancer, 2016-2018, UK.

 

Survival

Survive kidney cancer for 10 or more years, 2013-2017, England

Preventable cases

Kidney cancer cases are preventable, UK, 2015

 

  • There are around 13,100 new kidney cancer cases in the UK every year, that's 36 every day (2015-2017).
  • Kidney cancer is the 7th most common cancer in the UK, accounting for 4% of all new cancer cases (2017).
  • In females in the UK, kidney cancer is the 10th most common cancer, with around 4,900 new cases in 2017.
  • In males in the UK, kidney cancer is the 6th most common cancer, with around 8,100 new cases in 2017.
  • Incidence rates for kidney cancer in the UK are highest in people aged 85 to 89 (2015-2017).
  • Each year around a third (34%) of all new kidney cancer cases in the UK are diagnosed in people aged 75 and over (2015-2017).
  • Since the early 1990s, kidney cancer incidence rates have increased by almost nine-tenths (87%) in the UK. Rates in females have increased by almost two times (95%) and rates in males have increased by three-quarters (75%) (2015-2017).
  • Over the last decade, kidney cancer incidence rates have increased by more than a third (36%) in the UK. Rates in females have increased by almost two-fifths (38%), and rates in males have increased by almost a third (31%) (2015-2017).
  • More than 4 in 10 kidney cancer cases are diagnosed at a late stage in England (2014) and Northern Ireland (2010-2014).
  • Most kidney cancers occur in the kidney itself.
  • Incidence rates for kidney cancer are projected to rise by 26% in the UK between 2014 and 2035, to 32 cases per 100,000 people by 2035.
  • Kidney cancer incidence rates in England in females are 40% higher in the most deprived quintile compared with the least, and in males are 17% higher in the most deprived quintile compared with the least (2013-2017).
  • Around 1,100 cases of kidney cancer each year in England are linked with deprivation (around 580 in females and around 510 in males).
  • Kidney cancer is more common in White males than in Asian or Black males.
  • Kidney cancer is more common in White females than in Black females, but similar to Asian females, but Asian and Black females are similar to each other.
  • An estimated 46,800 people who had previously been diagnosed with kidney cancer were alive in the UK at the end of 2010.
  • There are around 4,600 kidney cancer deaths in the UK every year, that's 13 every day (2016-2018).
  • Kidney cancer is the 13th most common cause of cancer death in the UK, accounting for 3% of all cancer deaths (2018).
  • In females in the UK, kidney cancer is the 14th most common cause of cancer death, with around 1,700 deaths in 2018.
  • In males in the UK, kidney cancer is the 10th most common cause of cancer death, with around 2,900 deaths in 2018.
  • Mortality rates for kidney cancer in the UK are highest in people aged 90+ (2016-2018).
  • Each year more than half of all kidney cancer deaths (53%) in the UK are in people aged 75 and over (2016-2018).
  • Since the early 1970s, kidney cancer mortality rates have increased by almost three-quarters (73%) in the UK. Rates in females have increased by more than two-thirds (68%), and rates in males have increased by seven-tenths (70%).
  • Over the last decade, kidney cancer mortality rates have increased by around a twentieth (4%) in the UK. Rates in females have remained stable, and rates in males have remained stable.
  • Mortality rates for kidney cancer are projected to fall by 15% in the UK between 2014 and 2035, to 8 deaths per 100,000 people by 2035.
  • Kidney cancer deaths in England are more common in people living in the most deprived areas.

See more in-depth kidney cancer mortality statistics

  • Around 8 in 10 (79.3%) of people diagnosed with kidney cancer in England survive their disease for one year or more (2013-2017).
  • Almost 2 in 3 (63.8%) of people diagnosed with kidney cancer in England survive their disease for five years or more (2013-2017).
  • It is predicted that more than 1 in 2 (51.8%) of people diagnosed with kidney cancer in England survive their disease for ten years or more (2013-2017).
  • Kidney cancer survival for females is similar to males at one year, higher than for males at five years, and similar to males at ten-years.
  • Kidney cancer survival in England is highest for people diagnosed aged under 50 years old (2009-2013).
  • Around three-quarters of people in England diagnosed with Kidney cancer aged 15-49 survive their disease for five years or more, compared with more than a third of people diagnosed aged 80 and over (2009-2013).
  • Kidney cancer survival is improving and has increased in the last 40 years in the UK.
  • In the 1970s, almost a quarter of people diagnosed with kidney cancer survived their disease beyond ten years, now it's half.
  • When diagnosed at its earliest stage, more than 9 in 10 (96%) people with kidney cancer will survive their disease for one year or more, compared with around 4 in 10 (39%) people when the disease is diagnosed at the latest stage.
  • When diagnosed at its earliest stage, almost 9 in 10 (87%) people with kidney cancer will survive their disease for five years or more, compared with more than 1 in 10 (12%) people when the disease is diagnosed at the latest stage.
  • Five-year relative survival for kidney cancer in men and women is below the European average in England, Scotland, Wales and Northern Ireland.

See more in-depth kidney cancer survival statistics

  • A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • 1 in 34 UK males and 1 in 61 UK females will be diagnosed with kidney cancer in their lifetime.
  • 34% of kidney cancer cases in the UK are preventable.
  • 13% of kidney cancer cases in the UK are caused by smoking.
  • 24% of kidney cancer cases in the UK are caused by overweight and obesity.

See more in-depth kidney cancer risk statistics

  • 'GP referral' is the most common route to diagnosing kidney cancer.
  • GP referral is the route with the highest proportion of cases diagnosed at an early stage, for kidney cancer.
  • ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ and ‘62 day wait’ are not met by any country for urological cancers.
  • More than 4 in 10 kidney cancer cases are diagnosed at a late stage in England (2014) and Northern Ireland (2010-2014).
  • ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ and ‘62 day wait’ are not met by any country for urological cancers.
  • 56% of patients diagnosed with kidney cancer have surgery to remove the tumour as part of their primary cancer treatment.
  • 8% of patients diagnosed with kidney cancer have radiotherapy as part of their primary cancer treatment.
  • 13% of patients diagnosed with kidney cancer have chemotherapy as part of their primary cancer treatment.

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.